Holen Sie sich die Stockscreener-App
3.13
1.88%
-0.06
Handel nachbörslich:
3.11
-0.02
-0.64%
Finanzdaten der Wave Life Sciences Ltd-Aktie (WVE)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
94.06%
2.272
|
38.25 | 17.25 | 7.608 | 8.699 |
| Operating Expenses |
9.39%
76.07
|
69.54 | 73.71 | 63.96 | 61.46 |
| Operating Income/Loss |
135.80%
-73.80
|
-31.30 | -56.47 | -56.35 | -52.76 |
| Nonoperating Income/Loss |
14.66%
4.447
|
5.211 | 3.288 | 2.501 | 2.29 |
| Income/Loss From Continuing Operations Before Tax |
165.86%
-69.36
|
-26.09 | -53.18 | -53.85 | -50.47 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Net Income/Loss |
165.86%
-69.36
|
-26.09 | -53.18 | -53.85 | -50.47 |
| Basic Average Shares |
1.92%
204.01
|
200.17 | 3.8763 | 167.74 | 163.99 |
| Diluted Average Shares |
1.92%
204.01
|
200.17 | 3.8763 | 167.74 | 163.99 |
| Basic Earnings Per Share |
161.54%
-0.34
|
-0.13 | -0.29 | -0.32 | -0.31 |
| Diluted Earnings Per Share |
161.54%
-0.34
|
-0.13 | -0.29 | -0.32 | -0.31 |
1.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):